Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) Receivables (2013 - 2023)

Scynexis' (SCYX) quarterly Receivables came in at $19.4 million in Q4 2023, up 821.61% on a YoY basis from $2.1 million in Q4 2022, and down 10.17% quarter-over-quarter from $21.6 million in Q3 2023.

Analysis

Scynexis (SCYX) Receivables (2013 - 2023) Analysis & Trends

Scynexis (SCYX) has reported Receivables for 7 consecutive years, with $19.4 million the latest figure, recorded in Q4 2023.

  • For the quarter ending Q4 2023, Receivables rose 821.61% year-over-year to $19.4 million; the trailing twelve-month figure through Dec 2023 stood at $19.4 million (up 821.61% YoY), and the FY2023 full-year result was $19.4 million, up 821.61% from the prior year.
  • Receivables retreated to $19.4 million in Q4 2023 per SCYX's latest filing, from $21.6 million in the prior quarter.
  • Across five years, Receivables topped out at $21.6 million in Q2 2023 and bottomed at $29000.0 in Q3 2021.
  • Historically, Receivables has averaged $7.0 million across 4 years, with a median of $2.2 million in 2022.
  • The sharpest annual moves came in 2021 and 2022: Receivables tumbled 70.06% in 2021, then surged 8496.55% in 2022.
  • Over 4 years, Receivables stood at $2.9 million in 2020, then sank by 70.06% to $861000.0 in 2021, then surged by 144.02% to $2.1 million in 2022, then surged by 821.61% to $19.4 million in 2023.
  • According to Business Quant data, Receivables over the past three periods registered $19.4 million, $21.6 million, and $21.6 million for Q4 2023, Q3 2023, and Q2 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 10.23 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 5.90 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 2.13 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 6.57 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 1.93 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 160.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 912.74 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 1.89 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -
10 Scynexis 58.41 Mn -56.29 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 19.36 Mn
Sep 30, 2023 21.55 Mn
Jun 30, 2023 21.59 Mn
Mar 31, 2023 2.06 Mn
Dec 31, 2022 2.10 Mn
Sep 30, 2022 2.49 Mn
Jun 30, 2022 2.21 Mn
Mar 31, 2022 1.63 Mn
Dec 31, 2021 861,000.00
Sep 30, 2021 29,000.00
Dec 31, 2020 2.88 Mn
Mar 31, 2015 1.05 Mn
Dec 31, 2014 1.34 Mn
Sep 30, 2014 1.39 Mn
Jun 30, 2014 1.53 Mn
Mar 31, 2014 1.34 Mn
Dec 31, 2013 1.06 Mn